Treating hepatitis C in the prison popul
โ
Jennifer A. Tan; Tom A. Joseph; Sammy Saab
๐
Article
๐
2008
๐
John Wiley and Sons
๐
English
โ 147 KB
The prevalence of chronic hepatitis C infection in U.S. prisons is 12% to 31%. Treatment of this substantial portion of the population has been subject to much controversy, both medically and legally. Studies have demonstrated that treatment of chronic hepatitis C with pegylated interferon (PEG IFN)